Clik here to view.
CORRECTING and REPLACING BeiGene Completes 450 Million RMB (75 Million USD)...
BEIJING In the release dated November 14, 2014, references to “CITIC Capital Partners” should be “CITIC PE”. The boilerplate for CITIC Capital Partners should be replaced with the CITIC PE...
View ArticleClik here to view.
キャタレントがマイクロン・テクノロジーズを買収
米ニュージャージー州サマセット （ビジネスワイヤ） — 医薬品・生物製剤・コンシューマーヘルス製品向けの先進的送達技術と開発ソリューションを提供する世界的リーダー企業のキャタレント（NYSE:CTLT）は本日、粒径エンジニアリング技術を提供する世界一流企業のマイクロン・テクノロジーズを買収したと発表しました。...
View ArticleClik here to view.
Sierra Leone Action Receives Donation of Transfusion Medicine Equipment from...
FREETOWN, Sierra Leone Sierra Leone Action, an organization comprising a global team of Sierra Leonean physicians and other professionals, today announced that Fresenius Kabi has donated nine Fenwal...
View ArticleClik here to view.
Presbia Flexivue Microlens™ Receives Approval from Korean Ministry of Food...
AMSTERDAM Presbia announced today that its Presbia Flexivue Microlens™ has received regulatory approval from the Korean Ministry of Food and Drug Safety (MFDS) making this new treatment option for...
View ArticleClik here to view.
TechNavio Says Increased Outsourcing Activities Will Positively Affect Profit...
LONDON TechNavio, a tech-focused research firm has published a new report on the Global Oncology Biosimilars Market, which is expected to grow at a CAGR of 29.87 percent from 2014-2018. A good...
View ArticleClik here to view.
Quintiles Named a Best Workplace in South Korea
SEOUL, South Korea Quintiles announced today that it has been recognized as one of South Korea’s Best Workplaces by the Great Place to Work® Institute. This is Quintiles Korea’s first time to...
View ArticleClik here to view.
活动性银屑病关节炎患者口服OTEZLA® (Apremilast) 2年，显示有持久的临床缓解
新泽西州萨米特 (美国商业资讯) — Celgene Corporation (NASDAQ:CELG)今天宣布，在波士顿召开的美国风湿科学会(ACR)/风湿科卫生专业人员学会(ARHP)2014年年会上呈报了两项PALACE III期临床试验开放期OTEZLA® (apremilast)的长期（104周）有效性和安全性分析的结果。OTEZLA是该公司的磷酸二酯酶4 (PDE4)...
View ArticleClik here to view.
The Lancet Neurology Publishes Prana’s Huntington Disease Trial
MELBOURNE, Australia Prana Biotechnology (ASX:PBT)(NASDAQ:PRAN) has today announced the results of its Phase 2 trial in Huntington Disease, REACH2HD, has been published online in one of the world’s...
View ArticleClik here to view.
Sierra Leone Action接受Fresenius Kabi捐赠的输血医疗设备
塞拉利昂弗里敦 (美国商业资讯)–Sierra Leone Action是一家包含塞拉利昂医生和其他专业人员的全球性团队组织，该组织今天宣布，Fresenius Kabi已捐赠了9台Fenwal Autopheresis-C® 仪器，这些仪器均需要相关的耗材和培训，来研究埃博拉病毒疾病的治疗。Sierra Leone...
View ArticleClik here to view.
シエラレオネ・アクションがフレゼニウスカービより輸血用医療装置の寄贈を受ける
シエラレオネ・フリータウン （ビジネスワイヤ）– シエラレオネの医師やその他の専門家のグローバルチームから構成される組織のシエラレオネ・アクションは本日、フレゼニウスカービが9台のFenwal...
View ArticleClik here to view.
Duke University Researchers Visit NCKU for Future Collaboration
TAINAN, Taiwan Mani Daneshmand, Roberto Manson and Dawn E. Bowles from Duke University School of Medicine, United States, visited National Cheng Kung University (NCKU), southern Taiwan, on November...
View ArticleClik here to view.
PharmaEngine Announces the Receipt of US FDA Fast Track Designation for...
TAIPEI, Taiwan PharmaEngine, Inc. (TWO: 4162) and its partner Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) announced today that MM-398 (nanoliposomal irinotecan injection, also known as PEP02) has...
View ArticleClik here to view.
テラヴェクティスがレンチウイルスベクターを使用した治療用ワクチンの第I／II相試験の最新情報を提供
パリ （ビジネスワイヤ） — 完全統合型の創薬・臨床開発バイオテクノロジーを手掛ける企業として治療用ワクチンと免疫療法の開発に傾注するテラヴェクティスは、レンチウイルスベクターを使用した史上初のワクチン接種試験の有望な中間結果を報告します。...
View ArticleClik here to view.
Duke Surgery, NCKU Work to Better Develop New Cardiac Assist Device
TAINAN, Taiwan Dr. Mani Daneshmand, Dr. Roberto Manson and Dr. Dawn E. Bowles from Duke University School of Medicine, United States, joined a workshop held at the National Cheng Kung University...
View ArticleClik here to view.
Dr. Reddy’s Announces the Launch of Over-the-Counter Fexofenadine...
HYDERABAD, India Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched its over-the-counter (OTC) Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release...
View ArticleClik here to view.
Heritage Global Partners和联邦设备公司将处置先进生物制药设备和研发资产
魁北克和圣地亚哥 (美国商业资讯)–全球领先的资产咨询和拍卖服务公司Heritage Global Partners (“HGP”)以及联邦设备公司(Federal Equipment Company) (FEC)今天宣布，它们正在进行两场全球在线销售活动，出售世界领先的制药公司勃林格殷格翰(Boehringer...
View ArticleClik here to view.
ヘリテージ・グローバル・パートナーズとフェデラル・イクイップメント・カンパニーが最新鋭バイオ医薬品機器およびR&D資産の売却を管理
ケベック市 & サンディエゴ （ビジネスワイヤ） —...
View ArticleClik here to view.
Rohatyn Group完成向Advance Properties出售Huvepharma 36.6%股权的交易
纽约 (美国商业资讯)–专注于新兴市场的独立投资公司Rohatyn Group (“TRG”)今天宣布，TRG Growth Fund II已完成向Domuschiev家族控股的Advance Properties OOD出售Huvepharma AD 36.6%股权的交易。Huvepharma...
View ArticleClik here to view.
Cell Signaling Technology Wins “Best Antibodies” and “Most Useful Website” at...
WASHINGTON Cell Signaling Technology, a leading provider of antibodies, kits and services, announced today that it has won two Life Science Industry Awards® for “Best Antibodies” and “Most Useful...
View ArticleClik here to view.
ZOLL Files with Japan’s Pharmaceuticals and Medical Devices Agency for New...
CHELMSFORD, Mass. ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that its Japanese subsidiary, Asahi Kasei ZOLL Medical Corp. (AZM), has...
View Article